- Home
- CPA vs RYTM Comparison
CPA vs RYTM Comparison
Compare CPA & RYTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CPA
- RYTM
- Stock Information
- Founded
- CPA 1947
- RYTM 2008
- Country
- CPA Panama
- RYTM United States
- Employees
- CPA N/A
- RYTM N/A
- Industry
- CPA Air Freight/Delivery Services
- RYTM Biotechnology: Pharmaceutical Preparations
- Sector
- CPA Consumer Discretionary
- RYTM Health Care
- Exchange
- CPA Nasdaq
- RYTM Nasdaq
- Market Cap
- CPA 3.9B
- RYTM 3.2B
- IPO Year
- CPA 2005
- RYTM 2017
- Fundamental
- Price
- CPA $94.18
- RYTM $54.80
- Analyst Decision
- CPA Strong Buy
- RYTM Strong Buy
- Analyst Count
- CPA 7
- RYTM 12
- Target Price
- CPA $156.14
- RYTM $68.58
- AVG Volume (30 Days)
- CPA 319.0K
- RYTM 544.5K
- Earning Date
- CPA 05-14-2025
- RYTM 05-06-2025
- Dividend Yield
- CPA 6.84%
- RYTM N/A
- EPS Growth
- CPA 13.93
- RYTM N/A
- EPS
- CPA 14.56
- RYTM N/A
- Revenue
- CPA $3,444,630,000.00
- RYTM $130,126,000.00
- Revenue This Year
- CPA $7.15
- RYTM $47.06
- Revenue Next Year
- CPA $9.05
- RYTM $68.10
- P/E Ratio
- CPA $6.47
- RYTM N/A
- Revenue Growth
- CPA N/A
- RYTM 68.06
- 52 Week Low
- CPA $80.01
- RYTM $35.17
- 52 Week High
- CPA $114.00
- RYTM $68.58
- Technical
- Relative Strength Index (RSI)
- CPA 49.88
- RYTM 53.63
- Support Level
- CPA $94.96
- RYTM $52.54
- Resistance Level
- CPA $96.74
- RYTM $55.87
- Average True Range (ATR)
- CPA 2.08
- RYTM 2.15
- MACD
- CPA 0.06
- RYTM 0.47
- Stochastic Oscillator
- CPA 46.79
- RYTM 86.57
About CPA Copa Holdings S.A.
Copa Holdings SA is a provider of airline passenger and cargo services through its subsidiaries. The company operates through the air transportation segment. It offers international air transportation for passengers, cargo, and mail, operating from its Panama City hub in the Republic of Panama and domestic and international air transportation for passengers, cargo and mail with a point-to-point route network through Copa Colombia a Colombian air carrier. The company's geographical segments are North America, South America, Central America, and the Caribbean. It derives the maximum revenue from North America.
About RYTM Rhythm Pharmaceuticals Inc.
Rhythm Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. It is engaged in the development and commercialization of therapies for patients with rare diseases. The company is focused on its melanocortin-4 receptor (MC4R) agonists, including its lead asset, IMCIVREE (setmelanotide), as a precision medicine designed to treat hyperphagia and severe obesity caused by rare MC4R pathway diseases. Geographically the company generates its revenue from the United States and internationally with the majority being generated from the United States.